MARKET WIREStockInvest.us • 13h ago
Modular Medical Stock Price Forecast. Should You Buy MODD?StockInvest.us report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
Why MODD Stock Traded Steady Today — RQD Quant Desk Flash
$1.72 0.00% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $1.72
Modular Medical Inc. (MODD) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $16.3M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on MODD Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is MODD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Modular Medical Inc. (NASDAQ: MODD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $1.72 (0.00% 1D, market cap $16.3M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, MODD ranks #757 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does MODD compare to PAVM and RVP in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), MODD carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, PAVM (PAVmed Inc.) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $15.8M) and RVP (Retractable Technologies Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -23.3%, cap $17.3M). Among the 5-stock peer group, MODD leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for MODD?
▼
Per MODD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001074871), Modular Medical Inc. generated $0 in revenue, -$28.2M in net income, and -$27.7M in free cash flow against $10.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $1.72 (-0.19%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (33/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-11% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MODD)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (33/100 Composite)
🔍 WHY MODD SCORES 33/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (30% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9
▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (24% of score)
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 39.2 (NEUTRAL RANGE)
▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$2.68-22.8% Next Q
41
Q2 (-2Q)Grade E$2.07-20.3% Next Q
38
Q3 (-1Q)Grade E$1.65+4.2% Next Q
36
CurrentGrade E$1.72-8.9% Hist 90D α
33
Trajectory: D (41) → E (33)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a MODD Turnaround Squeeze
While MODD currently carries a cautious 33/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.47) and Max Pain ($1.81) forces dealer call-delta covering toward $19.59.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $MODD• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “MODD Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why MODD Stock Traded Steady Today — RQD Quant Desk Flash
Modular Medical Inc. (MODD) slipped 0.00% to $1.72, trading at 2% of its 52-week range ($1.52 – $18.66). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($1.52 – $18.66) with RSI-14 at 39.2 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.72 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52% gross margin and $0 annual free cash flow.
Live MODD Headlines & Catalysts
MARKET WIREStock Titan • 16h ago
A tubeless insulin pump is designed for three-day wear. Modular Medical's CEO is set to speak Oct. 14.Stock Titan report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo Finance • 19h ago
Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14thYahoo Finance report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 22h ago
Modular Medical Announces Positive Notified Body Decision on ISO 13485:2016 CertificationYahoo Finance report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
MARKET WIREBenzinga • 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
A pump maker gets a positive decision on quality certification. EU sales still require separate review.Stock Titan report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
CATALYSThttps://www.siam.in/ • 1d ago
Modular Medical (MODD) Jumps 18.7% to $2.73, Pressing Toward Resistance - Volume Breakout Ideashttps://www.siam.in/ report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
RISK WATCHhttps://www.dars.gov.et/ • 1d ago
MODD Q3 2025 Earnings: Wider-Than-Expected Loss Per Share as Development-Stage Device Maker Posts No Reported Revenue - ROA Comparisonhttps://www.dars.gov.et/ report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo • 18d ago
Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery SystemDeveloped in partnership with Relevate Health Games, the new tools use game-based technology to walk patients through the skills needed for insulin pump therapy. The resources are designed to help reduce barriers to adop
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MODD)
- ✓Walkthrough of MODD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
MODD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -57.74%🛡️ HOLDING TREND SUPPORT
2026-11-02O $1.91H $1.91L $1.72C $1.72VOL 17.0K
RES: $2.46SUP: $1.51SMA50: $2.47SMA200: $5.18
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
MODD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on MODD today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for MODD. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MODD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MODD)
Health Care Rank #757 of 1016
⚔️ PAVM vs MODD Full Matrix →
1. Head-to-Head Health Care Peer Comparison (MODD vs. PAVM, RVP, CTSO, PMI)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Modular Medical Inc. (MODD) ranks #757 by composite RQD confidence (33/100, grade E) and #850 by equity capitalization ($16.3M). Within this direct 5-issuer industry benchmark cohort, MODD leads on earnings valuation at N/A trailing P/E, while RVP leads on capital efficiency and profitability with -23.3% ROIC and 0.1% gross margin. PMI currently holds the highest overall quantitative score in the immediate peer group at 48/100 (D) compared with MODD at 33/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MODD
ACTIVE
Modular Medical Inc. | E | 33/100 | — | — | -35.0% | 0.00% | $16.3M | Benchmark Subject |
| PAVM PAVmed Inc. | E | 28/100 | — | -30.0% | -35.0% | -1.01% | $15.8M | /pavm-vs-modd → |
| RVP Retractable Technologies Inc. | E | 31/100 | — | 0.1% | -23.3% | -1.96% | $17.3M | /rvp-vs-modd → |
| CTSO Cytosorbents Corporation | E | 22/100 | — | 71.5% | -35.0% | +3.18% | $13.9M | /ctso-vs-modd → |
| PMI Picard Medical Inc. | D | 48/100 | — | — | — | +2.96% | $19.9M | /pmi-vs-modd → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001074871In its most recent audited fiscal period (FY2025, filed 2026-03-31), Modular Medical Inc. (MODD) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$28.2M, operating cash flow of -$23.8M, and free cash flow of -$27.7M (-52.0% YoY). On the balance sheet, MODD closed FY2025 with $10.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-03-31 | $0 | -$28.2M | -$23.8M | -$27.7M | $10.3M | — |
| FY2024 (FY) | 2025-03-31 | $0 | -$18.8M | -$15.7M | -$18.2M | $12.1M | — |
| FY2023 (FY) | 2024-03-31 | $0 | -$17.5M | -$14.0M | -$14.0M | — | — |
3. MODD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MODD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Modular Medical Inc. (NASDAQ: MODD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $1.72 (0.00% 1D, market cap $16.3M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, MODD ranks #757 in composite RQD confidence.
How does MODD compare to PAVM and RVP in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), MODD carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, PAVM (PAVmed Inc.) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $15.8M) and RVP (Retractable Technologies Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -23.3%, cap $17.3M). Among the 5-stock peer group, MODD leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MODD?
Per MODD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001074871), Modular Medical Inc. generated $0 in revenue, -$28.2M in net income, and -$27.7M in free cash flow against $10.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MODD trading relative to its 50-day, 200-day, and 52-week technical levels?
MODD last traded at $1.72 (0.00% on volume of 20,616 shares), positioning the stock -30.36% below its 50-day simple moving average ($2.47) and -66.80% below its 200-day simple moving average ($5.18). Across its 52-week range of $1.52 to $18.66, MODD sits at the 1.2% percentile with a 14-day RSI of 39.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.51 to $1.93).
MODD Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is MODD stock moving today?
Why MODD Stock Traded Steady Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 33/100 (E)
✓ STAGE-C NUMBER FIREWALL VERIFIED
MODD — Modular Medical Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:50:26Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, MODD scores 33 out of 100 with a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are:
- Fundamental Cash Engine: 7 / 20. Per the Roarable RQD rating, this pillar reflects ROIC of -35% and an FCF yield of 0%. For a prospective investor, this means the business is not currently generating a return on invested capital or free cash flow to shareholders, so the equity case rests on future operating change rather than present earnings power.
- Whale 13F Flow: 3 / 20. This pillar captures institutional accumulation and options positioning. The lowest-scoring pillar signals weak sponsorship from large institutional holders, which reduces the liquidity and confirmation support a prospective investor might otherwise rely on.
- Insider Conviction: 5 / 20. This pillar covers SEC Form 4 and Congressional PTR cluster flow. The low score indicates limited insider or disclosed-trader conviction behind the stock.
- Macro Regime Fit: 8 / 20. Per the Roarable RQD rating, beta is 1.0 with a sector sensitivity component. A beta of 1.0 means the stock is expected to move in line with the broad market; the score reflects that this neutral sensitivity does not offset the company-specific weaknesses.
- Forensic Balance Sheet: 10 / 20. Per the Roarable RQD rating, this pillar cites Altman Z 2.5, Piotroski F 2/9, and Debt/Equity 0.5. The Piotroski reading of 2 out of 9 is weak, while the Altman figure sits in a range the source does not further characterize; a prospective investor should weigh balance-sheet risk alongside the negative cash generation.
Taken together, the pillars point to a stock where the sharpest upside driver would be a credible turn toward positive cash generation, which the current data does not show. The valuation tradeoff is that a $16.3M market capitalization against a $-28.2M FY 2025 net income leaves little earnings-based valuation support in the source data. Investors should note that a 52-week range of $1.52 to $18.66 against a current price of 1.72 reflects a severe decline in the period covered.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $0.0M | $-27.6M | $-28.2M | N/A | $-27.7M | $2.9M | N/A |
| FY 2024 | $0.0M | $-19.0M | $-18.8M | N/A | $-18.2M | $7.0M | N/A |
| FY 2023 | $0.0M | $-17.5M | $-17.5M | N/A | $-14.0M | N/A | N/A |
Per the SEC financials, the company reported operating losses across all three periods, with net losses widening from $-17.5M in FY 2023 to $-28.2M in FY 2025. Gross, operating, and net margins are each reported as 0% in the market data, consistent with zero revenue. Per the Roarable RQD rating and market data, ROIC is -35%. Per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 2/9, and Debt/Equity is 0.5. Reported cash declined from $7.0M in FY 2024 to $2.9M in FY 2025 while free cash flow remained negative.
Recent Catalysts & News Wire Analysis
Per the recent news feed, the most recent items include:
- A StockInvest.us report on MODD market action and positioning (light: YELLOW, market wire).
- A Stock Titan report on an insulin pump designed for three-day wear, with the company's CEO scheduled to speak October 14 (light: YELLOW).
- A Yahoo Finance report that Modular Medical will present at the Webull Emerging & Innovative Companies Webinar on October 14th (light: GREEN, catalyst).
- A Yahoo Finance report on a positive Notified Body decision on ISO 13485:2016 certification (light: YELLOW).
- A Benzinga pre-market mention among 12 Health Care stocks (light: YELLOW).
- A Stock Titan report that a positive quality-certification decision was received, while EU sales still require separate review (light: YELLOW).
Positive catalysts in the feed are the ISO 13485:2016 certification decision and the scheduled investor presentation. Risk watch items are the continuing need for separate EU sales review and the absence of revenue in the financials. Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals.
Open Questions
- What products does Modular Medical sell, and what revenue has been or could be generated from them, given reported revenue of $0.0M?
- What is the status and expected timing of the separate EU sales review referenced in the news feed?
- What is the company's cash runway, given cash of $2.9M at FY 2025 against FY 2025 free cash flow of $-27.7M?
- What is the outstanding debt position, given that the debt line is N/A across all periods despite a Debt/Equity ratio of 0.5?
- What drove the decline in the stock from a 52-week high of $18.66 to a current price of 1.72, and is it associated with dilution, financing, or operational events?
MODD Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Modular Medical Inc. (MODD) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE StockInvest.us • 13h ago
Modular Medical Stock Price Forecast. Should You Buy MODD? StockInvest.us report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 16h ago
A tubeless insulin pump is designed for three-day wear. Modular Medical's CEO is set to speak Oct. 14. Stock Titan report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Yahoo Finance • 19h ago
Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th Yahoo Finance report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 22h ago
Modular Medical Announces Positive Notified Body Decision on ISO 13485:2016 Certification Yahoo Finance report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Benzinga • 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session Benzinga report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
A pump maker gets a positive decision on quality certification. EU sales still require separate review. Stock Titan report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST https://www.siam.in/ • 1d ago
Modular Medical (MODD) Jumps 18.7% to $2.73, Pressing Toward Resistance - Volume Breakout Ideas https://www.siam.in/ report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH https://www.dars.gov.et/ • 1d ago
MODD Q3 2025 Earnings: Wider-Than-Expected Loss Per Share as Development-Stage Device Maker Posts No Reported Revenue - ROA Comparison https://www.dars.gov.et/ report covering Modular Medical Inc. (MODD) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
MODD Bull vs. Bear Conversation Board — What's Your Call at $1.72?
🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MODD 🐻 67% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH
🎯 Target: $1.51 (-12.2%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is MODD (E • RQD 33/100) a Buy at $1.72?
Welcome to the MODD (Modular Medical Inc.) Roar Pit. Current RQD Composite is 33/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
FO ForensicBear Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $1.32 (-23.3%)
Spot @ $1.72 Pump the brakes on MODD — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on MODD, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Modular Medical Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
QU QuantViper Verified K Arena Trader 🐂 BULLISH
🎯 Target: $2.17 (+26.2%)
Spot @ $1.72 MODD cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on MODD, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $1.72 (52-wk range $1.52 - $18.66), any beat on forward guidance forces shorts and underweight funds to chase.